Cargando…
Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report
BACKGROUND: Although tumors of the lacrimal sac are rare, they represent a potentially life-threatening situation that can easily be overlooked since patients present with features consistent with chronic dacryocystitis. Lacrimal sac squamous cell carcinoma is the most common lacrimal sac malignancy...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353896/ https://www.ncbi.nlm.nih.gov/pubmed/36157994 http://dx.doi.org/10.12998/wjcc.v10.i21.7467 |
_version_ | 1784762951996014592 |
---|---|
author | Sun, Ming-Hui Yi, Wei-Dong Shen, Ling Zhou, Lu Lu, Jian-Xun |
author_facet | Sun, Ming-Hui Yi, Wei-Dong Shen, Ling Zhou, Lu Lu, Jian-Xun |
author_sort | Sun, Ming-Hui |
collection | PubMed |
description | BACKGROUND: Although tumors of the lacrimal sac are rare, they represent a potentially life-threatening situation that can easily be overlooked since patients present with features consistent with chronic dacryocystitis. Lacrimal sac squamous cell carcinoma is the most common lacrimal sac malignancy, but no definitive treatment is currently available. CASE SUMMARY: We describe a 34-year-old unmarried male who presented with a red and swollen right lower eyelid, which gradually developed into a mass of the lower eyelid that obstructed vision in his right eye. He was treated with transcatheter arterial infusion chemotherapy and interventional embolization based on the tumor characteristics, and we also administered intensity-modulated radiotherapy and targeted therapy after tumor shrinkage. The tumor treatment demonstrated good efficacy, and the patient’s condition was stable after 10 mo of follow-up. CONCLUSION: To our knowledge, this is the first report of lacrimal sac squamous cell carcinoma treated with transcatheter arterial infusion chemotherapy and interventional embolization, which might expand clinical treatment options for lacrimal sac carcinoma. |
format | Online Article Text |
id | pubmed-9353896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-93538962022-09-23 Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report Sun, Ming-Hui Yi, Wei-Dong Shen, Ling Zhou, Lu Lu, Jian-Xun World J Clin Cases Case Report BACKGROUND: Although tumors of the lacrimal sac are rare, they represent a potentially life-threatening situation that can easily be overlooked since patients present with features consistent with chronic dacryocystitis. Lacrimal sac squamous cell carcinoma is the most common lacrimal sac malignancy, but no definitive treatment is currently available. CASE SUMMARY: We describe a 34-year-old unmarried male who presented with a red and swollen right lower eyelid, which gradually developed into a mass of the lower eyelid that obstructed vision in his right eye. He was treated with transcatheter arterial infusion chemotherapy and interventional embolization based on the tumor characteristics, and we also administered intensity-modulated radiotherapy and targeted therapy after tumor shrinkage. The tumor treatment demonstrated good efficacy, and the patient’s condition was stable after 10 mo of follow-up. CONCLUSION: To our knowledge, this is the first report of lacrimal sac squamous cell carcinoma treated with transcatheter arterial infusion chemotherapy and interventional embolization, which might expand clinical treatment options for lacrimal sac carcinoma. Baishideng Publishing Group Inc 2022-07-26 2022-07-26 /pmc/articles/PMC9353896/ /pubmed/36157994 http://dx.doi.org/10.12998/wjcc.v10.i21.7467 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Case Report Sun, Ming-Hui Yi, Wei-Dong Shen, Ling Zhou, Lu Lu, Jian-Xun Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report |
title | Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report |
title_full | Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report |
title_fullStr | Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report |
title_full_unstemmed | Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report |
title_short | Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report |
title_sort | transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353896/ https://www.ncbi.nlm.nih.gov/pubmed/36157994 http://dx.doi.org/10.12998/wjcc.v10.i21.7467 |
work_keys_str_mv | AT sunminghui transcatheterarterialinfusionchemotherapyandembolizationforprimarylacrimalsacsquamouscellcarcinomaacasereport AT yiweidong transcatheterarterialinfusionchemotherapyandembolizationforprimarylacrimalsacsquamouscellcarcinomaacasereport AT shenling transcatheterarterialinfusionchemotherapyandembolizationforprimarylacrimalsacsquamouscellcarcinomaacasereport AT zhoulu transcatheterarterialinfusionchemotherapyandembolizationforprimarylacrimalsacsquamouscellcarcinomaacasereport AT lujianxun transcatheterarterialinfusionchemotherapyandembolizationforprimarylacrimalsacsquamouscellcarcinomaacasereport |